ABSTRACT
The 2002 and 2005 recommendations of the European Society of Cardiology for the management of ST-elevation myocardial infarction at the acute stage are reviewed. Primary angioplasty should, whenever possible, constitute the default strategy, but intravenous thrombolysis still has an important role, particularly in the first few hours following symptom onset.
Subject(s)
Myocardial Infarction/therapy , Myocardial Reperfusion/methods , Algorithms , Angioplasty, Balloon , Electrocardiography , Humans , Myocardial Infarction/diagnosis , Practice Guidelines as Topic , Thrombolytic Therapy , Time FactorsABSTRACT
This paper reviews current evidence on the role of admission and fasting glycaemia as prognostic markers in patients with acute coronary syndromes. Though both parameters are correlated, they give different prognostic information and are related to both in-hospital complications, including death, and long-term outcomes. As hyperglycemia at the acute stage of myocardial infarction is an independent predictor of untoward cardiovascular events, blood glucose measurements should become routine in all patients presenting with acute coronary syndromes.